Realbotix

No company has been chasing this dream longer. Realbotix grew out of Abyss Creations, the studio that has hand-built hyper-realistic silicone humans under the RealDoll name since the 1990s. Its founder, Matt McMullen, spent two decades perfecting the body; Realbotix is the project to give that body a mind and a face that moves. In 2024 it became a public company the unglamorous way — a reverse-takeover of Andrew Kiguel's listed Tokens.com shell — and now trades on the TSX Venture exchange as a micro-cap, with Kiguel as CEO and McMullen shifted to chief creative officer.

The bet: craft over scale

Where every other name in this directory races toward legs, labour, or mass manufacturing, Realbotix is betting on the opposite: silicone craft and emotional presence. Its flagship Aria and travel-friendly Melody are conversational, endlessly customisable, expressive from the chest up, and unmistakably luxury objects, launched north of six figures. They do not walk; they sit or ride a wheeled base, expressive above the waist and static below.

On October 26, 2026 Realbotix cut the price of entry sharply. Its new Echo line, which it calls its flagship platform, sells Aria alongside three other personas (Mila, Dave and Amar) at $11,950 for a tabletop unit or $59,950 for a full body, plus a required AI plan from $19.99 a month. A $199 deposit reserves a place in a first run of 250 units, due for delivery in the second half of 2027 and only in the US, and Echo is sold only through Realbotix. The older F-Series (Aria) and M-Series (Melody) bodies are no longer on its site. They were last listed in September 2026, from $125,000 and $95,000, and Realbotix hasn't said whether it still sells them, so confirm with the company. It is still the closest thing this directory has to a companion-robot pure-play, and lately the company has also been repositioning the same lifelike-interface technology as "embodied AI" for enterprise (telecom, healthcare, hospitality), not just the bedroom.

Where it stands

Two things keep the story honest. The robots are expensive and the volumes are tiny. Consolidated revenue was $932,000 in the nine months to June 30, 2026, down from $2.1 million a year earlier as sales at its Intima subsidiary fell back after a prior-year backlog, and the robotics unit itself booked $184,000 over those nine months from robot deliveries and event support. (Its first genuine commercial deployment, a Vinci-vision robot delivered to Ericsson, came in April 2026.) And the hardest problem — a face convincing in motion rather than in a photo — is one even the category's most experienced maker hasn't fully solved.

The corporate structure is in flux too. In February 2026 Realbotix agreed to sell Realbotix LLC, the robotics unit, to Nasdaq-listed Onconetix in an all-stock deal, first expected to close by the end of the third quarter and then in the fourth. On the August earnings call Kiguel said the agreement's end date had always been the end of November. As of October 27, Onconetix still said it "intends to file" the Form S-4 registration it needs for a shareholder vote, and it had advanced $3 million of a $5 million bridge loan to fund the unit in the meantime.

But if anyone has earned the right to try, it's the people who have been building artificial people the longest. The 2024 stunt of naming its own AI robot, Aria, a non-executive board advisor was pure marketing; the twenty years of silicone craft behind her are not.